One Hour Preoperative Gatifloxacin - Full Text View

Home Search Study Topics Glossary

One Hour Preoperative Gatifloxacin

This study is currently recruiting participants.

Verified by Stanford University, January 2007

First Received: July 5, 2006 Last Updated: January 23, 2007 History of Changes

Sponsored by:	Stanford University
Information provided by:	Stanford University
ClinicalTrials.gov Identifier:	NCT00350363

Purpose

Comparison of 1 day versus 1 hour application of topical Zymar.

Condition	Intervention	Phase
Ophthalmic Surgery	Drug: Zymar	Phase IV

Study Type:	Interventional
Study Design:	Non-Randomized, Single Blind, Dose Comparison, Parallel Assignment
Official Title:	One Hour Preoperative Gatifloxacin

Resource links provided by NLM:

Drug Information available for: Gatifloxacin

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350363

Contacts

Contact: Christopher Ta, MD

650-725-6995

Locations

United States, California
Stanford	Recruiting
Stanford, California, United States, 94304

Sponsors and Collaborators

Stanford University

Investigators

Principal Investigator:

Christopher Ta, MD

Stanford University

More Information

No publications provided

Study ID Numbers:	5004
Study First Received:	July 5, 2006
Last Updated:	January 23, 2007
ClinicalTrials.gov Identifier:	NCT00350363 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Gatifloxacin

Additional relevant MeSH terms:

Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Gatifloxacin

ClinicalTrials.gov processed this record on July 02, 2009